Position in MREO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$954,000
-$1,382,088 QoQ
Shares Held
3,000,000
-57.6% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#5
of 58 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MREO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Newtyn Management, LLC holds $80,524,145 across 6 Biotechnology names. MREO ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TBPH |
Theravance Biopharma, Inc.
|
3,434,191 | $58,381,247 | |
| 2 | RCKT |
Rocket Pharmaceuticals, Inc.
|
4,000,000 | $13,680,000 | |
| 3 | ATAI |
AtaiBeckley Inc.
|
1,187,808 | $6,259,748 | |
| 4 | WVE |
Wave Life Sciences, Inc.
|
215,000 | $1,249,150 | |
| 5 | MREO |
Mereo BioPharma Group plc
This page
|
3,000,000 | $954,000 | |
| 6 | 709,247 | $0 |
All Filings in MREO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $954,000 | 3,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,336,088 | 7,079,056 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $93,667 | 224,622 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||